Continued value of the serum alpha-fetoprotein test in surveilling at-risk populations for hepatocellular carcinoma.

HCC cases detected by the AFP test without abnormal ultrasonic findings appear to have better survival, possibly as a result of stage migration and the resulting cures. Complementary AFP surveillance, together with US, could be helpful for at-risk patients.